Related Experiment Video
Updated: Oct 26, 2025

07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.1K
Cross-Link-Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications
Zhuoran Ma1, Feifei Wang1, Yeteng Zhong1
1Department of Chemistry and Bio-X, Stanford University Stanford, CA 94305 (USA).
Summary
Researchers developed new biocompatible quantum dots (QDs) that are quickly cleared from the body. These P3-QDs enable precise in vivo imaging of immune cells and tumors, improving cancer therapy monitoring.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Imaging
Background:
- Near-infrared IIb (NIR-IIb) fluorophores often exhibit prolonged retention in vivo.
- Developing biocompatible probes with rapid clearance is crucial for advanced molecular imaging.
Purpose of the Study:
- To create novel NIR-IIb emitting quantum dots (QDs) with enhanced biocompatibility and rapid in vivo clearance.
- To functionalize these QDs for targeted imaging of CD8+ cytotoxic T lymphocytes (CTLs) in response to immunotherapy.
- To demonstrate the utility of these probes for multiplexed in vivo imaging.
Main Methods:
- Functionalization of core/shell lead sulfide/cadmium sulfide quantum dots (PbS/CdS QDs) with a novel cross-linked amphiphilic polymeric coating (P3 coating).
- Conjugation of P3-QDs to an engineered anti-CD8 diabody (Cys-diabody) for specific targeting of CTLs.
- Two-plex molecular imaging using P3-QDs and down-conversion Erbium nanoparticles (ErNPs) with NIR-IIb light sheet microscopy.
Main Results:
- The P3 coating ensured high biocompatibility and >90% excretion of QDs within 2 weeks post-administration.
- Achieved real-time, in vivo, cellular-resolution imaging of PD-L1 positive tumor cells and CTLs.
- Demonstrated imaging of tumor angiogenesis and deep lymph nodes with a high signal-to-background ratio (up to ~170).
Conclusions:
- The novel P3-coated QDs offer a promising solution for rapid clearance and biocompatibility in NIR-IIb imaging.
- This platform enables effective in vivo monitoring of therapeutic responses, particularly for immunotherapy targeting CTLs.
- The developed imaging approach facilitates detailed visualization of the tumor microenvironment and immune cell infiltration.

